For the year ending 2025-12-31, ADMA made $510,173K in revenue. $146,930K in net income. Net profit margin of 28.80%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenues | 510,173 | |||
| Cost of product revenue | 217,408 | |||
| Gross profit | 292,765 | |||
| Research and development | 4,762 | |||
| Plasma center operating expenses | 4,836 | |||
| Amortization of intangible assets | 144 | |||
| Selling, general and administrative | 91,580 | |||
| Total operating expenses | 101,322 | |||
| Income from operations | 191,443 | |||
| Interest income | 1,871 | |||
| Interest expense | 7,110 | |||
| Loss on extinguishment of debt | -3,336 | |||
| Other expense | -212 | |||
| Other expense, net | -8,787 | |||
| Income (loss) before income taxes | 182,656 | |||
| Income tax expense (benefit) | 35,726 | |||
| Net income (loss) | 146,930 | |||
| Basic EPS | 0.62 | |||
| Diluted EPS | 0.6 | |||
| Basic Average Shares | 238,299,024 | |||
| Diluted Average Shares | 244,904,640 | |||
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)